COVID in Iowa: Monoclonal antibodies show promise, avert hospital stays
Des Moines Register Thousands of Iowans potentially escaped being hospitalized with COVID-19, or worse, after being treated by experimental monoclonal antibodies. The treatment arrived in Iowa in mid-November, shortly after it received emergency approval by federal regulators, and it has shown promising results in keeping Iowans sick with COVID-19 from the direst of outcomes. The treatment isn’t for everyone who tests positive for the coronavirus. It is generally reserved for people with a higher risk of hospitalization or more dire outcomes from the virus. And while its first deployment ...